110 related articles for article (PubMed ID: 8572463)
1. [Modalities of follow-up after excision of stage I melanoma: practice survey in hospitals].
Couilliet D; Poisson-Salomon AS; Cosquer M; Guillaume JC
Ann Dermatol Venereol; 1995; 122(5):263-6. PubMed ID: 8572463
[No Abstract] [Full Text] [Related]
2. [Professional practice in stage I melanoma. A national survey of dermatologists].
Poisson-Salomon AS; Mlika-Cabanne N; Cosquer M; Durieux P; Saiag P
Ann Dermatol Venereol; 1995; 122(5):259-62. PubMed ID: 8572462
[No Abstract] [Full Text] [Related]
3. [Inpatient and outpatient follow-up of grade I malignant melanoma].
Cordel N; Safa G; Balguerie X; De Preville P; Modeste A; Courville P; Boivin C; Pellerin A; Ziade J; Thiberville G; Laaengh-Michel N; Neveu C; Young P; Lauret P; Joly P
Ann Dermatol Venereol; 2000; 127(6-7):579-83. PubMed ID: 10930854
[TBL] [Abstract][Full Text] [Related]
4. [Are there special therapeutic methods recommended by some physicians for the management of stage I melanoma?].
Revuz J
Ann Dermatol Venereol; 1995; 122(5):319-20. PubMed ID: 8572474
[No Abstract] [Full Text] [Related]
5. [Impact of French consensus conference concerning the follow-up of patients surgically treated for stage I melanoma among French dermatologists and oncologists].
Bafounta ML; Beauchet A; Poisson-Salomon AS; Saiag P
Ann Dermatol Venereol; 1999 Nov; 126(11):795-800. PubMed ID: 10612855
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and treatment of malignant melanoma of the skin (a lecture)].
Denisov LE; Kurdina MI
Khirurgiia (Mosk); 1996; (1):17-22. PubMed ID: 8683912
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of paraclinical follow-up in stage I melanoma.
Bastien M; Tessier MH; Legoux B; Litoux P; Bureau B; Dréno B
Arch Dermatol; 1997 Nov; 133(11):1462-3. PubMed ID: 9371039
[No Abstract] [Full Text] [Related]
8. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
[TBL] [Abstract][Full Text] [Related]
9. Is sentinel node status predictive of overall survival in patients with melanoma?
Carlson GW
Nat Clin Pract Oncol; 2005 Oct; 2(10):494-5. PubMed ID: 16205765
[No Abstract] [Full Text] [Related]
10. [After excision of primary stage I cutaneous melanoma, is an initial evaluation necessary?].
Richard-Lallemand MA
Ann Dermatol Venereol; 1995; 122(5):349-59. PubMed ID: 8572478
[No Abstract] [Full Text] [Related]
11. [What are expected improvements in the follow-up and treatment of stage I melanoma?].
Thomas L
Ann Dermatol Venereol; 1995; 122(5):378-88. PubMed ID: 8572482
[No Abstract] [Full Text] [Related]
12. Management of melanoma patients: benefit of intense follow-up schedule is not demonstrated.
Autier P; Coebergh JW; Boniol M; Dore JF; de Vries E; Eggermont AM
J Clin Oncol; 2003 Oct; 21(19):3707; author reply 3707-8. PubMed ID: 14512409
[No Abstract] [Full Text] [Related]
13. [Clinical trial of local immunomodulation with DNCB in cases of advanced melanoma of the skin].
Budzanowska E; Pawlicki M
Przegl Dermatol; 1988; 75(1):29-34. PubMed ID: 3290999
[No Abstract] [Full Text] [Related]
14. Massive nodular melanoma: a case report.
Harting M; Tarrant W; Kovitz CA; Rosen T; Harting MT; Souchon E
Dermatol Online J; 2007 May; 13(2):7. PubMed ID: 17498426
[TBL] [Abstract][Full Text] [Related]
15. Giant tumor of the back.
Eisen DB; Lack EE; Boisvert M; Nigra TP
Arch Dermatol; 2002 Sep; 138(9):1245-50. PubMed ID: 12224992
[No Abstract] [Full Text] [Related]
16. Follow-up schedules after treatment for malignant melanoma.
Francken AB; Accortt NA; Shaw HM; Colman MH; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
Br J Surg; 2008 Nov; 95(11):1401-7. PubMed ID: 18844268
[TBL] [Abstract][Full Text] [Related]
17. [Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an M0 cutaneous melanoma, full report. National Federation of Cancer Campaign Centers. French Dermatology Society. Update of the 1995 Consensus Conference and the 1998 Standards, Options, and Recommendations].
Négrier S; Saiag P; Guillot B; Verola O; Avril MF; Bailly C; Cupissol D; Dalac S; Danino A; Dreno B; Grob JJ; Leccia MT; Renaud-Vilmer C; Bosquet L; ;
Ann Dermatol Venereol; 2005 Dec; 132(12 Pt 2):10S3-10S85. PubMed ID: 16521904
[No Abstract] [Full Text] [Related]
18. Cutaneous melanoma: detecting it earlier, weighing management options.
Lane JE; Dalton RR; Sangueza OP
J Fam Pract; 2007 Jan; 56(1):18-28. PubMed ID: 17217894
[No Abstract] [Full Text] [Related]
19. [Implication of French general practitioners in the follow-up of patients surgically treated for stage I melanoma].
Bafounta ML; Beauchet A; Poisson-Salomon AS; Saiag P
Ann Dermatol Venereol; 1999 Nov; 126(11):801-3. PubMed ID: 10612856
[TBL] [Abstract][Full Text] [Related]
20. [Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma. Fédération Nationale des Centres de Lutte Contre le Cancer].
Négrier S; Fervers B; Bailly C; Beckendorf V; Cupissol D; Doré JF; Dorval T; Garbay JR; Vilmer C
Bull Cancer; 2000 Feb; 87(2):173-82. PubMed ID: 10705288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
